Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Allogene Therapeutics key operating metrics including Office and Laboratory Space, square feet, environmental, and social and governance score (ESG).

Office and Laboratory Space, square feet

200.9K
9.7%

FY, 2019

Phase I Trials Products

4
300.0%

FY, 2019

Pre-Clinical Phase Products

8
14.3%

FY, 2019

Operating Metrics

MetricsFY, 2018FY, 2019
Office and Laboratory Space, square feet222.5K200.9K
Phase I Trials Products14
Pre-Clinical Phase Products78
Patients Included in Clinical Trials2121

Environmental, Social and Governance (ESG)

Overall

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu